Newton, Massachusetts
United States
67
2026-05-07
The entities that hold a legal rights for patent applications filed by inventor BRODNEY Michael Aaron:
Michael Aaron BRODNEY from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
#2 | 2024-11-07INHIBITORS OF APOL1 AND METHODS OF USING SAME
#3 | 2024-10-10MODULATORS OF ALPHA-1 ANTITRYPSIN
#4 | 2024-09-26HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
#5 | 2024-06-135,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES
#6 | 2023-10-26MODULATORS OF ALPHA-1 ANTITRYPSIN
#7 | 2023-08-24MODULATORS OF ALPHA-1 ANTITRYPSIN
#8 | 2023-06-225,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES
#9 | 2023-06-22PIPERAZINE AZASPIRO DERIVATIVES
#10 | 2023-05-25PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
#11 | 2023-05-257- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
#12 | 2023-05-25INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
#13 | 2023-05-25PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
#14 | 2022-04-07Inhibitors of APOL1 and methods of using same
#15 | 2021-11-18Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
#16 | 2021-10-07Heterocyclic Spiro Compounds As MAGL Inhibitors
#17 | 2021-10-075,7-dihydro-pyrrolo-pyridine derivatives
#18 | 2021-09-30Heteroaromatic compounds and their use as dopamine D1 ligands
#19 | 2021-06-17Modulators of alpha-1 antitrypsin
#20 | 2021-01-28Piperazine azaspiro derivatives
#21 | 2020-11-19Modulators of alpha-1 antitrypsin
#22 | 2020-09-10Heteroaromatic compounds and their use as dopamine D1 ligands
#23 | 2020-08-20Dihydro-pyrrolo-pyridine derivatives
#24 | 2020-07-025,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES
#25 | 2019-12-191,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#26 | 2019-12-05Heteroaromatic compounds and their use as dopamine D1 ligands
#27 | 2019-09-26Heterocyclic spiro compounds as MAGL inhibitors
#28 | 2019-09-121,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors
#29 | 2019-01-03Heteroaromatic compounds and their use as dopamine D1 ligands
#30 | 2018-07-26HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS
#31 | 2018-07-261,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors
#32 | 2018-05-31Heteroarylphenoxy benzamide kappa opioid ligands
#33 | 2018-03-081,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#34 | 2018-02-08Heteroaromatic compounds and their use as dopamine D1 ligands
#35 | 2018-01-045,7-dihydro-pyrrolo-pyridine derivatives
#36 | 2017-12-28N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8H)-YL)-thiazol-4-YL) amides
#37 | 2017-10-26N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides
#38 | 2017-10-262-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
#39 | 2017-06-012-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
#40 | 2017-03-30N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides
#41 | 2017-03-30N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides
#42 | 2017-03-30N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides
#43 | 2017-03-02Heteroaromatic compounds and their use as dopamine D1 ligands
#44 | 2017-02-16Heterocyclic compounds and their use as dopamine D1 ligands
#45 | 2017-02-021,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#46 | 2017-01-122-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
#47 | 2016-07-14Heteroaromatic compounds and their use as dopamine D1 ligands
#48 | 2016-06-022-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
#49 | 2016-01-21PYRIDINE DERIVATIVES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#50 | 2016-01-07Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#51 | 2015-12-31Substituted phenyl hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds
#52 | 2015-10-29Substituted 1,7-naphthyridines as dopamine D1 ligands
#53 | 2015-10-152-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
#54 | 2015-08-20Hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds
#55 | 2015-08-13Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#56 | 2015-07-16Heteroaromatic compounds and their use as dopamine D1 ligands
#57 | 2015-06-25Heteroaromatic compounds and their use as dopamine D1 ligands
#58 | 2015-05-14Heterocyclic Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
#59 | 2015-03-26Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#60 | 2015-01-01Heteroaromatic compounds and their use as dopamine D1 ligands
#61 | 2014-12-11Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#62 | 2014-10-30Hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds
#63 | 2014-08-14Heteroaryl-substituted hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds
#64 | 2014-06-12Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#65 | 2013-11-07Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
#66 | 2013-06-13Novel Sultam Compounds
#67 | 2013-02-28Hexahydropyrano[3,4-][1,3]thiazin-2-amine compounds
116190 ⎘